Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001781011 | SCV002017346 | likely pathogenic | Thyroid dyshormonogenesis 6 | 2021-05-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002034589 | SCV002116543 | pathogenic | not provided | 2024-03-19 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 879 of the DUOX2 protein (p.Glu879Lys). This variant is present in population databases (rs774556391, gnomAD 0.1%). This missense change has been observed in individual(s) with congenital hypothyroidism (PMID: 18765513, 25248169, 26349762, 26709262, 29650690, 32425884). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1324306). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DUOX2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects DUOX2 function (PMID: 25248169). For these reasons, this variant has been classified as Pathogenic. |
Juno Genomics, |
RCV001781011 | SCV005417875 | pathogenic | Thyroid dyshormonogenesis 6 | criteria provided, single submitter | clinical testing | PM3_VeryStrong+PP4+PS3_Supporting | |
Fulgent Genetics, |
RCV001781011 | SCV005630721 | likely pathogenic | Thyroid dyshormonogenesis 6 | 2024-05-23 | criteria provided, single submitter | clinical testing |